Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China
· Delayed Price · Currency is CNY 54.56
-0.73 (-1.32%)
Mar 10, 2026, 2:34 PM CST
SHA:603334 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 154.44 | 123.82 | 129.71 | 133.35 | 101.91 | 49 |
| Depreciation & Amortization | 19.59 | 19.59 | 18.14 | 12.25 | 10.24 | 7.27 |
| Other Amortization | 2.26 | 2.26 | 2.27 | 1.5 | 0.29 | 1.17 |
| Loss (Gain) From Sale of Assets | -0.05 | -0.05 | -0.02 | 0.06 | 0.41 | - |
| Asset Writedown & Restructuring Costs | 0.06 | 0.06 | 0.76 | 1.7 | 1.63 | 0.07 |
| Loss (Gain) From Sale of Investments | -0.7 | -0.7 | 3.98 | 5.07 | - | - |
| Provision & Write-off of Bad Debts | 4.56 | 4.56 | -3.17 | 1.9 | 2.11 | 1.38 |
| Other Operating Activities | -102.02 | 2.68 | 10.88 | -2.86 | 3.12 | 8.03 |
| Change in Accounts Receivable | -118.19 | -118.19 | 66.43 | -92.78 | -84.3 | -31.7 |
| Change in Inventory | -44.27 | -44.27 | -96.73 | 13.55 | 9.96 | 14.61 |
| Change in Accounts Payable | 32.81 | 32.81 | 1.47 | 36.21 | 41.85 | 25.09 |
| Change in Other Net Operating Assets | 3.28 | 3.28 | 28.86 | -40.24 | -6.7 | -0.33 |
| Operating Cash Flow | -51.65 | 22.43 | 162.5 | 69.72 | 76.95 | 74.88 |
| Operating Cash Flow Growth | - | -86.20% | 133.07% | -9.40% | 2.77% | - |
| Capital Expenditures | -26.96 | -79.53 | -168.11 | -80.1 | -71.94 | -16.03 |
| Sale of Property, Plant & Equipment | 0.17 | 0.17 | 0.18 | 0.36 | 0.52 | - |
| Investment in Securities | - | - | 0.18 | 0.02 | -2.3 | 1.87 |
| Other Investing Activities | -1.7 | 0.44 | 0.34 | -7.42 | 1.31 | -1.04 |
| Investing Cash Flow | -28.49 | -78.92 | -167.41 | -87.14 | -72.41 | -15.2 |
| Long-Term Debt Issued | - | 315.2 | 248.98 | 328.57 | 164.9 | 101.62 |
| Long-Term Debt Repaid | - | -242.86 | -245.3 | -219.45 | -124.9 | -104.62 |
| Net Debt Issued (Repaid) | 69.65 | 72.34 | 3.68 | 109.12 | 40 | -3 |
| Issuance of Common Stock | - | - | - | 14.1 | - | 20 |
| Common Dividends Paid | -10.22 | -10.63 | -25.37 | -22 | -3.87 | -3.33 |
| Other Financing Activities | 15.53 | 3.2 | -4.52 | -3.21 | -0.34 | -47.57 |
| Financing Cash Flow | 74.96 | 64.91 | -26.2 | 98.01 | 35.79 | -33.9 |
| Foreign Exchange Rate Adjustments | 4.61 | 4.65 | 2.94 | 10.34 | -1.86 | -2.37 |
| Net Cash Flow | -0.57 | 13.07 | -28.18 | 90.93 | 38.47 | 23.4 |
| Free Cash Flow | -78.61 | -57.1 | -5.62 | -10.38 | 5.01 | 58.84 |
| Free Cash Flow Growth | - | - | - | - | -91.49% | - |
| Free Cash Flow Margin | -2.79% | -2.93% | -0.33% | -0.61% | 0.39% | 7.45% |
| Free Cash Flow Per Share | -0.73 | -0.53 | -0.05 | -0.10 | 0.05 | 0.59 |
| Cash Income Tax Paid | 39.03 | -10.36 | 48.84 | 43.27 | 41.59 | 8.28 |
| Levered Free Cash Flow | - | -148.93 | -84.83 | 48.87 | 1.9 | - |
| Unlevered Free Cash Flow | - | -145.18 | -80.38 | 52.8 | 3.99 | - |
| Change in Working Capital | -129.79 | -129.79 | -0.07 | -83.25 | -42.76 | 7.96 |
Source: S&P Capital IQ. Standard template. Financial Sources.